Nina R. Shah

University of California, San Francisco — United States

Medicine · Health Sciences

8h-index623citations60works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell Adhesion Molecules Research(21), Endometrial and Cervical Cancer Treatments(15), Protease and Inhibitor Mechanisms(10), Caveolin-1 and cellular processes(8), Cancer Risks and Factors(7)

Publications60 total

Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials
UNC Libraries·2025Open Access
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
UNC Libraries·2025Open Access
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial
UNC Libraries·2025Open Access
Abstract 7128: Neoantigen expression and expansion of cytotoxic T cell clonotypes in multiple myeloma patients receiving a personalized cancer vaccine post-transplant: Insights from the BM CTN 1401 multicenter trial
Cancer Research·2025
Neoantigen Expression and Expansion of Cytotoxic T Cell Clonotypes in Multiple Myeloma Patients Randomized to Post-Transplant Treatment with a Personalized Cancer Vaccine Under the BM CTN 1401 Multicenter Trial.
Transplantation and Cellular Therapy·2025
Associations of obesity with post-treatment risks of cervical precancer and cancer
American Journal of Obstetrics and Gynecology·2024· 4 cited
Supplementary Table 2 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 3 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 5 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Data from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Methods from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 4 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 3 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Methods from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 1 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 4 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Table 2 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Table 1 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 2 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 5 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Kristy Ward(38), Cheryl Saenz(20), Michael McHale(20), Steven C. Plaxe(19), Isabelle Tancioni(19), Sean Uryu(19), Florian J. Sulzmaier(19), Christine Lawson(19), Christine Jean(19), David D. Schlaepfer(19), Nichol Miller(18), Xiao Lei Chen(18), M.A. Davis(13), L.M. Bean(5), Angelica M. Roncancio(4), Edwin Alvarez(3), Philip E. Castle(3), Nancy Poitras(3), Megan A. Clarke(3), Thomas Lorey(3)